ConductScience.org, home

Paper21085486

Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.

Vaine M and 7 others. PLoS One, 2010. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies. Papers, record 21085486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21085486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.
PubMed
Journal
PLoS One
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
0.93
iCite
Revised in PubMed
2023-11-05
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vaine MMichael
2Wang SShixia
3Liu QQin
4Arthos JJames
5Montefiori DDavid
6Goepfert PPaul
7McElrath MJM Juliana
8Lu SShan

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS VaccinesMajor topic
HIV AntibodiesMajor topic
HIV Envelope Protein gp120Major topic
HIV InfectionsMajor topic
Antibodies, Neutralizing
Antibody Specificity
Antibody-Dependent Cell Cytotoxicity
Enzyme-Linked Immunosorbent Assay
HIV-1
Humans

Source PubMed

Download CSV of topics

Grants11

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI082274NIAID NIH HHSUnited StatesP01AI082274PubMed and NIHNIH RePORTER
AI082676NIAID NIH HHSUnited StatesU19AI082676PubMed and NIHNIH RePORTER
AI065250NIAID NIH HHSUnited StatesR01AI065250PubMed and NIHNIH RePORTER
U19 AI082676NIAID NIH HHSUnited StatesU19AI082676PubMed and NIHNIH RePORTER
R01 AI065250NIAID NIH HHSUnited StatesR01AI065250PubMed and NIHNIH RePORTER
P01 AI082274NIAID NIH HHSUnited StatesP01AI082274PubMed and NIHNIH RePORTER
U01 AI068618NIAID NIH HHSUnited StatesU01AI068618PubMed and NIHNIH RePORTER
AI 27742NIAID NIH HHSUnited StatesP30AI027742PubMed and NIHNIH RePORTER
P30 AI027742NIAID NIH HHSUnited StatesP30AI027742PubMed and NIHNIH RePORTER
R21 AI087191NIAID NIH HHSUnited StatesR21AI087191PubMed and NIHNIH RePORTER
ZIAAI000883NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00027365An Investigational Combination Vaccine Given to People Who Are Not Infected With HIVResults

Source ClinicalTrials.gov

Download CSV of trials

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112190851Postnatal pre- and postexposure passive immunization strategies: protection of neonatal macaques against oral simian-human immunodeficiency virus challenge.J Med Primatol2002https://conductscience.org/library/papers/12190851PubMed
217721546Broad HIV-1 neutralization mediated by CD4-binding site antibodies.Nat Med2007https://conductscience.org/library/papers/17721546PubMed
319287373Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.Nature2009https://conductscience.org/library/papers/19287373PubMed
416989638Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.Expert Rev Vaccines2006https://conductscience.org/library/papers/16989638PubMed
512743303Characterization of a conformational epitope on hepatitis B virus core antigen and quasiequivalent variations in antibody binding.J Virol2003https://conductscience.org/library/papers/12743303PubMed
619004942Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals.J Virol2009https://conductscience.org/library/papers/19004942PubMed
719012954Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.Lancet2008https://conductscience.org/library/papers/19012954PubMed
815752839Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.Vaccine2005https://conductscience.org/library/papers/15752839PubMed
916306625Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag.J Virol2005https://conductscience.org/library/papers/16306625PubMed
1016912322
Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.
J Virol2006https://conductscience.org/library/papers/16912322PubMed
1110196297Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.J Virol1999https://conductscience.org/library/papers/10196297PubMed
129593008
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group.
J Infect Dis1998https://conductscience.org/library/papers/9593008PubMed
1317038830Role of neutralizing antibodies in protective immunity against HIV.Hum Vaccin2005https://conductscience.org/library/papers/17038830PubMed
1418833271Challenges in the development of an HIV-1 vaccine.Nature2008https://conductscience.org/library/papers/18833271PubMed
1516343526A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.J Immunol Methods2006https://conductscience.org/library/papers/16343526PubMed
168794312The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate.J Virol1996https://conductscience.org/library/papers/8794312PubMed
1719729618Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.Science2009https://conductscience.org/library/papers/19729618PubMed
1818833294B cell recognition of the conserved HIV-1 co-receptor binding site is altered by endogenous primate CD4.PLoS Pathog2008https://conductscience.org/library/papers/18833294PubMed
1915867093Antigenic conservation and immunogenicity of the HIV coreceptor binding site.J Exp Med2005https://conductscience.org/library/papers/15867093PubMed
2011462019Postnatal passive immunization of neonatal macaques with a triple combination of human monoclonal antibodies against oral simian-human immunodeficiency virus challenge.J Virol2001https://conductscience.org/library/papers/11462019PubMed

See all 36 referencesDownload CSV of references

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
38773089Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains.Nat Commun2024https://conductscience.org/library/papers/38773089PubMed
36009408Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections.Biomedicines2022https://conductscience.org/library/papers/36009408PubMed
35140230Broadly binding and functional antibodies and persisting memory B cells elicited by HIV vaccine PDPHV.NPJ Vaccines2022https://conductscience.org/library/papers/35140230PubMed
32747654Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature.Sci Rep2020https://conductscience.org/library/papers/32747654PubMed
30615119Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period.J Infect Dis2019https://conductscience.org/library/papers/30615119PubMed
28933684Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines.Hum Vaccin Immunother2017https://conductscience.org/library/papers/28933684PubMed
28701402Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.J Virol2017https://conductscience.org/library/papers/28701402PubMed
28615206Plasticity and Epitope Exposure of the HIV-1 Envelope Trimer.J Virol2017https://conductscience.org/library/papers/28615206PubMed
27455880Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques.Mol Ther2016https://conductscience.org/library/papers/27455880PubMed
27048742DNA immunization as a technology platform for monoclonal antibody induction.Emerg Microbes Infect2016https://conductscience.org/library/papers/27048742PubMed
26656117Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination.Clin Vaccine Immunol2016https://conductscience.org/library/papers/26656117PubMed
26590319A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines.J Immunol2016https://conductscience.org/library/papers/26590319PubMed
26491157Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity.J Virol2016https://conductscience.org/library/papers/26491157PubMed
26344472DNA Immunization for HIV Vaccine Development.Vaccines (Basel)2014https://conductscience.org/library/papers/26344472PubMed
26344467Pilot Study on the Use of DNA Priming Immunization to Enhance Y. pestis LcrV-Specific B Cell Responses Elicited by a Recombinant LcrV Protein Vaccine.Vaccines (Basel)2013https://conductscience.org/library/papers/26344467PubMed
26109728Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL.J Virol2015https://conductscience.org/library/papers/26109728PubMed
25245278HIV-1 envelope glycoprotein trimer immunogenicity elicited in the presence of human CD4 alters the neutralization profile.AIDS Res Hum Retroviruses2014https://conductscience.org/library/papers/25245278PubMed
25202303The influence of delivery vectors on HIV vaccine efficacy.Front Microbiol2014https://conductscience.org/library/papers/25202303PubMed
25013066A critical question for HIV vaccine development: which antibodies to induce?Science2014https://conductscience.org/library/papers/25013066PubMed
24794644Mucosal vaccines against respiratory syncytial virus.Curr Opin Virol2014https://conductscience.org/library/papers/24794644PubMed

See all 33 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene
NDUFB34709PubTator's text mininghttps://conductscience.org/library/genes/4709NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21085486

GET https://conductscience.org/api/papers/v1/21085486/references?page=2